Early diagnosis of AL, the use of novel therapies, such as bortezomib and the anti-CD38 monoclonal antibodies, and, in a selected group of patients, high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) improve the OS of patients with AL [15,16]. This evidence concerns the gene CD38 and axial length measurement.